ANGLE’s (AGL) Buy Rating Reaffirmed at Berenberg Bank

Berenberg Bank restated their buy rating on shares of ANGLE (LON:AGL) in a research report sent to investors on Wednesday, MarketBeat.com reports. They currently have a GBX 40 ($0.50) price objective on the stock.

ANGLE Stock Performance

Shares of AGL stock opened at GBX 14.75 ($0.18) on Wednesday. The firm has a 50 day moving average of GBX 10.98 and a 200-day moving average of GBX 11.17. The company has a market cap of £47.57 million, a price-to-earnings ratio of -210.70 and a beta of 0.22. The company has a quick ratio of 6.18, a current ratio of 5.19 and a debt-to-equity ratio of 17.22. ANGLE has a 52 week low of GBX 7.11 ($0.09) and a 52 week high of GBX 25.13 ($0.31).

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.